Home LiteratureArticle Details
PMID: 18701703 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Spatiotemporal analysis of differential Akt regulation in plasma membrane microdomains.

Molecular biology of the cell ·Vol. 19 ·No. 10 ·2008-10-00 ·Pages 4366-73

Gao X, Zhang J

Abstract

As a central kinase in the phosphatidylinositol 3-kinase pathway, Akt has been the subject of extensive research; yet, spatiotemporal regulation of Akt in different membrane microdomains remains largely unknown. To examine dynamic Akt activity in membrane microdomains in living cells, we developed a specific and sensitive fluorescence resonance energy transfer-based Akt activity reporter, AktAR, through systematic testing of different substrates and fluorescent proteins. Targeted AktAR reported higher Akt activity with faster activation kinetics within lipid rafts compared with nonraft regions of plasma membrane. Disruption of rafts attenuated platelet-derived growth factor (PDGF)-stimulated Akt activity in rafts without affecting that in nonraft regions. However, in insulin-like growth factor-1 (IGF)-1 stimulation, Akt signaling in nonraft regions is dependent on that in raft regions. As a result, cholesterol depletion diminishes Akt activity in both regions. Thus, Akt activities are differentially regulated in different membrane microdomains, and the overall activity of this oncogenic pathway is dependent on raft function. Given the increased abundance of lipid rafts in some cancer cells, the distinct Akt-activating characteristics of PDGF and IGF-1, in terms of both effectiveness and raft dependence, demonstrate the capabilities of different growth factor signaling pathways to transduce differential oncogenic signals across plasma membrane.

MeSH Terms
Animals Cell Membrane/metabolism Cell Proliferation Cholesterol/metabolism Gene Expression Regulation, Enzymologic Humans Insulin-Like Growth Factor I/metabolism Membrane Microdomains/metabolism Mice Models, Biological NIH 3T3 Cells Protein Structure, Tertiary Proto-Oncogene Proteins c-akt/metabolism Signal Transduction/physiology Time Factors
Chemicals
Insulin-Like Growth Factor I Cholesterol Proto-Oncogene Proteins c-akt
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Gao Xinxin
Department of Pharmacology and Molecular Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Zhang Jin
References (42)
42 references, click to expand
  1. Signal propagation from membrane messengers to nuclear effectors revealed by reporters of phosphoinositide dynamics and Akt activity.
    Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15081-6 PMID: 16214892
  2. The molecular basis of FHA domain:phosphopeptide binding specificity and implications for phospho-dependent signaling mechanisms.
    Mol Cell. 2000 Nov;6(5):1169-82 PMID: 11106755
  3. Cholesterol sensitivity of endogenous and myristoylated Akt.
    Cancer Res. 2007 Jul 1;67(13):6238-46 PMID: 17616681
  4. Expanded dynamic range of fluorescent indicators for Ca(2+) by circularly permuted yellow fluorescent proteins.
    Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10554-9 PMID: 15247428
  5. Mutation analysis of the PTEN/MMAC1 gene in lung cancer.
    Oncogene. 1998 Sep 24;17(12):1557-65 PMID: 9794233
  6. Subcellular dynamics of protein kinase A activity visualized by FRET-based reporters.
    Biochem Biophys Res Commun. 2006 Sep 22;348(2):716-21 PMID: 16895723
  7. Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies.
    Biochim Biophys Acta. 2007 Jun;1768(6):1311-24 PMID: 17493580
  8. Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts.
    J Clin Invest. 2005 Apr;115(4):959-68 PMID: 15776112
  9. Spatio-temporal dynamics of protein kinase B/Akt signaling revealed by a genetically encoded fluorescent reporter.
    J Biol Chem. 2005 Feb 18;280(7):5581-7 PMID: 15583002
  10. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas.
    Int J Cancer. 1995 Aug 22;64(4):280-5 PMID: 7657393
  11. Critical role for lipid raft-associated Src kinases in activation of PI3K-Akt signalling.
    Cell Signal. 2007 May;19(5):1081-92 PMID: 17275257
  12. Evolutionary optimization of fluorescent proteins for intracellular FRET.
    Nat Biotechnol. 2005 Mar;23(3):355-60 PMID: 15696158
  13. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth.
    Mol Cell. 2005 Apr 1;18(1):13-24 PMID: 15808505
  14. Adipose development: from stem cell to adipocyte.
    Crit Rev Biochem Mol Biol. 2005 Jul-Aug;40(4):229-42 PMID: 16126487
  15. Ten years of protein kinase B signalling: a hard Akt to follow.
    Trends Biochem Sci. 2001 Nov;26(11):657-64 PMID: 11701324
  16. Cell cycle and death control: long live Forkheads.
    Trends Biochem Sci. 2002 Jul;27(7):352-60 PMID: 12114024
  17. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells.
    Oncogene. 1999 Nov 25;18(50):7034-45 PMID: 10597304
  18. The phosphatidylinositol 3-Kinase AKT pathway in human cancer.
    Nat Rev Cancer. 2002 Jul;2(7):489-501 PMID: 12094235
  19. Fluorescent indicators for Akt/protein kinase B and dynamics of Akt activity visualized in living cells.
    J Biol Chem. 2003 Aug 15;278(33):30945-51 PMID: 12773546
  20. Ras proteins: different signals from different locations.
    Nat Rev Mol Cell Biol. 2003 May;4(5):373-84 PMID: 12728271
  21. Why is PTEN an important tumor suppressor?
    J Cell Biochem. 2007 Dec 15;102(6):1368-74 PMID: 17972252
  22. Dynamic FoxO transcription factors.
    J Cell Sci. 2007 Aug 1;120(Pt 15):2479-87 PMID: 17646672
  23. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms.
    Mol Cell. 2007 Mar 23;25(6):917-31 PMID: 17386267
  24. Creating new fluorescent probes for cell biology.
    Nat Rev Mol Cell Biol. 2002 Dec;3(12):906-18 PMID: 12461557
  25. Targeting the PI3K-Akt pathway in human cancer: rationale and promise.
    Cancer Cell. 2003 Oct;4(4):257-62 PMID: 14585353
  26. Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells.
    Science. 2002 May 3;296(5569):913-6 PMID: 11988576
  27. Cholesterol, lipid rafts, and disease.
    J Clin Invest. 2002 Sep;110(5):597-603 PMID: 12208858
  28. AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells.
    Am J Pathol. 2001 Aug;159(2):431-7 PMID: 11485901
  29. Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines.
    J Biol Chem. 1999 Jul 30;274(31):21528-32 PMID: 10419456
  30. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation.
    Am J Pathol. 2000 Oct;157(4):1123-8 PMID: 11021816
  31. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes.
    Mol Cell Biol. 2004 Oct;24(19):8778-89 PMID: 15367694
  32. Genetically encoded reporters of protein kinase A activity reveal impact of substrate tethering.
    Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):14997-5002 PMID: 11752448
  33. A motif-based profile scanning approach for genome-wide prediction of signaling pathways.
    Nat Biotechnol. 2001 Apr;19(4):348-53 PMID: 11283593
  34. High affinity binding of inositol phosphates and phosphoinositides to the pleckstrin homology domain of RAC/protein kinase B and their influence on kinase activity.
    J Biol Chem. 1997 Mar 28;272(13):8474-81 PMID: 9079675
  35. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha.
    Curr Biol. 1997 Apr 1;7(4):261-9 PMID: 9094314
  36. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.
    Cancer Res. 1997 Nov 1;57(21):4710-3 PMID: 9354427
  37. Lipid rafts and membrane traffic.
    FEBS Lett. 2007 May 22;581(11):2098-104 PMID: 17382322
  38. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region.
    Science. 1991 Oct 11;254(5029):274-7 PMID: 1833819
  39. Analyzing protein kinase dynamics in living cells with FRET reporters.
    Methods. 2006 Nov;40(3):279-86 PMID: 16908183
  40. Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents.
    Am J Pathol. 2006 Apr;168(4):1107-18; quiz 1404-5 PMID: 16565487
  41. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer.
    Nature. 2007 Jul 26;448(7152):439-44 PMID: 17611497
  42. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.
    Science. 2005 Feb 18;307(5712):1098-101 PMID: 15718470
Article Info
Journal
Molecular biology of the cell
Abbr.
Mol Biol Cell
ISSN
1939-4586
Published
2008-10-00
Epub
2008-00-13
Pages
4366-73
Language
English
Region
United States
NLM ID
9201390
PMCID
PMC2555921
Subset
IM
Grants
NIDDK NIH HHS · R01 DK073368 · United States
NCI NIH HHS · R21 CA122673 · United States
NIDDK NIH HHS · R01 DK-073368 · United States
NCI NIH HHS · R21 CA-122673 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com